Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey W. Sherman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James E. Flynn - $25.00M in LRMR purchases and sales in the last 12 months
- Kevin McCulloch - $1.36M in XERS purchases and sales in the last 12 months
- Beth Hecht - $1.34M in XERS purchases and sales in the last 12 months
- Thomas Edward Hamilton - $667K in LRMR purchases and sales in the last 12 months
- Steven Pieper - $515K in XERS purchases and sales in the last 12 months
- John Patrick Shannon Jr. - $173K in XERS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey W. Sherman?
Jeffrey W. Sherman is a corporate insider of Larimar Therapeutics, Inc. (LRMR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jeffrey W. Sherman last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 5 filings going back to 2025.
Has Jeffrey W. Sherman been buying or selling stock?
Recorded transactions: 1 open-market purchase ($25K) and 1 open-market sale ($335K) across all tracked filings.
